Employee Stories
Upholding the philosophy of “Employee Development”,
Luye Pharma regards employees as the most valuable resources of the company
About Us
Luye Pharma Group (02186.HK), a member of Luye Life Sciences Group, is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications.
Luye Pharma Announces Successful Completion of a U.S. Bridging Clinical Trial of Its Innovative Drug LY03015 (VMAT2 Inhibitor/Sigma-1R Agonist)
News
Shanghai, August 5, 2026 — Luye Pharma Group today announced the successful completion of a U.S. bridging clinical trial of its in-house developed new molecular entity, LY03015. The results support the commencement of the upcoming efficacy ...
August 05,2026
Luye Pharma Announces Positive Phase 2 Results of LY03015, a VMAT2 Inhibitor and Sigma-1R Agonist, for Tardive Dyskinesia in China
Study Met Primary Endpoint; AIMS Response Rate Reached 76.5% in the 20mg Dose Group Shanghai, June 16, 2026 -- Luye Pharma Group today announced that a Phase 2 clinical trial in China evaluating its LY03015 in patients with tardive dyskinesia ...
June 16,2026
Investors
New Year, New Team, New Power
Interview with Employees of Luye Pharma UK and Functional Team Members
A Dream of Thirteen Years
Interview with Project Team Members of LY01005
Historic Breakthrough, Brand New Journey
The Story of Rykindo® (LY03004) Approval in the U.S.
My Three Years with Luye US
Antonia Sacchetti
Office Manager, Luye Pharma (US)
Learn the Best of the People around You
Yan Yameng
HR BP, Luye Pharma
To Practice with Every Opportunity
Wang Chao
Director of Engineering Department II, Shandong Luye
